Congleton Jon

Mineralys Therapeutics, Inc. ยท Chief Executive Officer

Congleton Jon is listed in public filings as director, officer: Chief Executive Officer. This Congleton Jon insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Mineralys Therapeutics, Inc. (MLYS). Investors use Congleton Jon's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Mineralys Therapeutics, Inc.MLYS$18M689.3k sharesSellApr 13, 2026$422.0K15.7k shares$26.83--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Mineralys Therapeutics, Inc.MLYS$19M705.5k sharesSellMar 31, 2026$1.5M55.2k shares$26.54--
Mineralys Therapeutics, Inc.MLYS$19M760.7k sharesSellMar 31, 2026$493.8K19.4k shares$25.50--
Mineralys Therapeutics, Inc.MLYS$19M705.1k sharesSellMar 31, 2026$12.3K453 shares$27.05--
Mineralys Therapeutics, Inc.MLYS$5.3M187.9k sharesGrant / ExerciseFeb 19, 2026$5.3M187.9k shares$28.06--
Mineralys Therapeutics, Inc.MLYS--780.1k sharesGrant / ExerciseFeb 19, 2026Disclosure amount unavailable140.9k shares----
Mineralys Therapeutics, Inc.MLYS$21M646.3k sharesSellJan 12, 2026$293.7K9.1k shares$32.21--
Mineralys Therapeutics, Inc.MLYS$21M639.2k sharesSellJan 12, 2026$235.9K7.1k shares$33.15--
Mineralys Therapeutics, Inc.MLYS$024.1k sharesGrant / ExerciseNov 21, 2025$13.0K24.1k shares$0.54--
Mineralys Therapeutics, Inc.MLYS$30M664.2k sharesSellNov 11, 2025$5.1M112.3k shares$45.83--
Mineralys Therapeutics, Inc.MLYS$30M631.3k sharesSellNov 11, 2025$1.5M32.9k shares$46.89--
Mineralys Therapeutics, Inc.MLYS$35M776.4k sharesSellNov 11, 2025$1.3M29.2k shares$45.20--
Mineralys Therapeutics, Inc.MLYS$34M818.5k sharesSellNov 11, 2025$533.2K12.8k shares$41.64--
Mineralys Therapeutics, Inc.MLYS$34M809.6k sharesSellNov 11, 2025$374.9K8.9k shares$42.31--
Mineralys Therapeutics, Inc.MLYS$35M805.6k sharesSellNov 11, 2025$174.0K4k shares$43.50--
Mineralys Therapeutics, Inc.MLYS$36M832.9k sharesSellOct 13, 2025$577.5K13.5k shares$42.63--
Mineralys Therapeutics, Inc.MLYS$36M831.3k sharesSellOct 13, 2025$66.8K1.6k shares$43.03--
Mineralys Therapeutics, Inc.MLYS$12M846.4k sharesSellJul 11, 2025$230.4K15.9k shares$14.51--
Mineralys Therapeutics, Inc.MLYS$11M862.3k sharesSellApr 11, 2025$186.8K15.3k shares$12.19--
Mineralys Therapeutics, Inc.MLYS$5.8M570k sharesGrant / ExerciseFeb 13, 2025$5.8M570k shares$10.20--
Mineralys Therapeutics, Inc.MLYS$8.0M877.6k sharesSellJan 13, 2025$166.1K18.3k shares$9.06--
Mineralys Therapeutics, Inc.MLYS$12M895.9k sharesSellOct 11, 2024$206.4K15.3k shares$13.52--
Mineralys Therapeutics, Inc.MLYS$12M911.2k sharesSellJul 11, 2024$210.1K15.7k shares$13.34--
Mineralys Therapeutics, Inc.MLYS$11M927k sharesSellJun 20, 2024$175.2K14.9k shares$11.73--
Mineralys Therapeutics, Inc.MLYS$11M941.9k sharesSellJun 18, 2024$199.1K16.6k shares$11.99--
Mineralys Therapeutics, Inc.MLYS$12M958.5k sharesSellJun 17, 2024$217.7K17.8k shares$12.25--
Mineralys Therapeutics, Inc.MLYS$12M976.3k sharesSellJun 14, 2024$203.2K16.2k shares$12.52--
Mineralys Therapeutics, Inc.MLYS$13M992.5k sharesSellJun 13, 2024$509.0K40k shares$12.74--
Mineralys Therapeutics, Inc.MLYS$13M1M sharesSellJun 12, 2024$212.0K16.6k shares$12.77--
Congleton Jon | TradingNote